Targeting Energy Expenditure-Drugs for Obesity Treatment.

Jimenez-Munoz, Carlos M; López, Marta; Albericio, Fernando; Makowski, Kamil

Jimenez-Munoz, Carlos M; López, Marta; Albericio, Fernando; Makowski, Kamil.

Afiliación

Jimenez-Munoz CM; School of Chemical Sciences and Engineering Yachay Tech University, San Miguel de Urcuquí 100119, Ecuador.
López M; School of Chemical Sciences and Engineering Yachay Tech University, San Miguel de Urcuquí 100119, Ecuador.
Albericio F; Department of Surfactants and Biotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), 08034 Barcelona, Spain.
Makowski K; CIBER-BBN, Networking Centre of Bioengineering, Biomaterials, and Nanomedicine, and Department of Organic Chemistry, University of Barcelona, 08028 Barcelona, Spain.

Pharmaceuticals (Basel) ; 14(5)2021 May 06.

Article en En | MEDLINE | ID: mdl-34066399

Palabras clave

FDA-approved; clinical trials; energy expenditure; energy metabolism; obesity; thermogenesis; treatments under development; withdrawn treatments

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Ecuador

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google